Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cordes

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Annals of Nuclear Medicine|September 11, 2019
PSMA SPECT/CT with <sup>99m</sup>Tc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levelsChristian Schmidkonz, Theresa Ida Goetz, Torsten Kuwert, et al.
Nuklearmedizin. Nuclear Medicine|July 15, 2020
Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancerTheresa Ida Götz, Elmar Wolfgang Lang, Olaf Prante, et al.
Clinical Nuclear Medicine|December 27, 2019
99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive LesionsChristian Schmidkonz, Armin Atzinger, Theresa Ida Goetz, et al.
Clinical Nuclear Medicine|June 20, 2020
99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate CancerChristian Schmidkonz, Theresa Ida Götz, Armin Atzinger, et al.
Annals of Nuclear Medicine|July 25, 2019
68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patientsChristian Schmidkonz, Michael Cordes, Theresa Ida Goetz, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2020
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNAChristian Schmidkonz, Manuela Krumbholz, Armin Atzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2019
Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNAChristian Schmidkonz, Manuela Krumbholz, Armin Atzinger, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Annals of Nuclear Medicine|September 11, 2019
PSMA SPECT/CT with <sup>99m</sup>Tc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levelsChristian Schmidkonz, Theresa Ida Goetz, Torsten Kuwert, et al.
Nuklearmedizin. Nuclear Medicine|July 15, 2020
Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancerTheresa Ida Götz, Elmar Wolfgang Lang, Olaf Prante, et al.
Clinical Nuclear Medicine|December 27, 2019
99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive LesionsChristian Schmidkonz, Armin Atzinger, Theresa Ida Goetz, et al.
Clinical Nuclear Medicine|June 20, 2020
99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate CancerChristian Schmidkonz, Theresa Ida Götz, Armin Atzinger, et al.
Annals of Nuclear Medicine|July 25, 2019
68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patientsChristian Schmidkonz, Michael Cordes, Theresa Ida Goetz, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2020
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNAChristian Schmidkonz, Manuela Krumbholz, Armin Atzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2019
Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNAChristian Schmidkonz, Manuela Krumbholz, Armin Atzinger, et al.
Pageof 3